• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  liposomal amikacin
Date Designated:  08/25/2009
Orphan Designation:  Treatment of bronchiectasis in patients with Pseudomonas aeruginosa or other susceptible microbial pathogens
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Insmed, Inc.
Princeton Corpoarate Plaza
Suite C
Monmouth Junction, New Jersey 08852
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.